Treatment of intestinal pythiosis in a dog with a combination of marginal excision, chemotherapy, and immunotherapy.
METHODS
A 1.5-year-old mixed-breed dog was examined because of a 1-month history of anorexia, vomiting, diarrhea, and weight loss.


RESULTS
The dog was very thin on physical examination (body condition score, 3/9). Results of all diagnostic tests were within reference limits except intestinal thickening and lymphadenopathy were identified on abdominal ultrasound examination. During exploratory laparotomy, thickening at the ileocecal-colic junction and within the transverse colon and mesenteric lymphadenopathy were identified, and the ileocecal-colic junction was resected. Histopathologic evaluation of the ileocecal-colic junction and full-thickness biopsy specimens from other sites as well as results of a serum ELISA were diagnostic for gastrointestinal Pythium insidiosum infection.


RESULTS
Pythiosis was initially treated medically with administration of itraconazole and terbinafine by mouth, but the colonic lesion was progressive with this regimen. Two months after diagnosis, a subtotal colectomy was performed; marginal excision (0.6 cm) was obtained at the aboral margin. The dog was treated with 3 doses of a pythiosis vaccine beginning approximately 2 weeks after surgery and was continued on itraconazole and terbinafine for 5 months. Parenteral and enteral nutrition as well as considerable general supportive care were required postoperatively. Six months after treatment, the dog had a normal serum ELISA titer. Two years after treatment, the dog had returned to preoperative weight and was clinically normal.


CONCLUSIONS
This patient had an unusually positive therapeutic response to chronic, extensive, marginally excised gastrointestinal pythiosis.
Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA. cws@uga.edu
Chad W
CW
Schmiedt
Meri
M
Stratton-Phelps
Bryan T
BT
Torres
Dennis
D
Bell
Elizabeth W
EW
Uhl
Shawn
S
Zimmerman
Jason
J
Epstein
Karen K
KK
Cornell
D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004283:Dog Diseases / Q000382:microbiology* / Q000473:pathology / Q000628:therapy; D004285:Dogs; D000077422:Enrofloxacin; D024841:Fluoroquinolones / Q000627:therapeutic use; D007410:Intestinal Diseases / Q000382:microbiology / Q000628:therapy / Q000662:veterinary*; D017964:Itraconazole / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009281:Naphthalenes / Q000008:administration & dosage / Q000627:therapeutic use; D058968:Pythiosis / Q000628:therapy / Q000662:veterinary*; D011775:Pythium / Q000276:immunology; D000077291:Terbinafine; D014612:Vaccines / Q000276:immunology*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009281:Naphthalenes; D014612:Vaccines; D017964:Itraconazole; D000077422:Enrofloxacin; D000077291:Terbinafine